These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 29496041)
1. Double positivity for HPV-DNA/p16 Mena M; Taberna M; Tous S; Marquez S; Clavero O; Quiros B; Lloveras B; Alejo M; Leon X; Quer M; Bagué S; Mesia R; Nogués J; Gomà M; Aguila A; Bonfill T; Blazquez C; Guix M; Hijano R; Torres M; Holzinger D; Pawlita M; Pavon MA; Bravo IG; de Sanjosé S; Bosch FX; Alemany L Oral Oncol; 2018 Mar; 78():137-144. PubMed ID: 29496041 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma. Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895 [TBL] [Abstract][Full Text] [Related]
3. Analysis of p53, p16(INK4a), pRb and Cyclin D1 expression and human papillomavirus in primary ovarian serous carcinomas. Bilyk OO; Pande NT; Buchynska LG Exp Oncol; 2011 Sep; 33(3):150-6. PubMed ID: 21956468 [TBL] [Abstract][Full Text] [Related]
4. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients. Castellsagué X; Alemany L; Quer M; Halec G; Quirós B; Tous S; Clavero O; Alòs L; Biegner T; Szafarowski T; Alejo M; Holzinger D; Cadena E; Claros E; Hall G; Laco J; Poljak M; Benevolo M; Kasamatsu E; Mehanna H; Ndiaye C; Guimerà N; Lloveras B; León X; Ruiz-Cabezas JC; Alvarado-Cabrero I; Kang CS; Oh JK; Garcia-Rojo M; Iljazovic E; Ajayi OF; Duarte F; Nessa A; Tinoco L; Duran-Padilla MA; Pirog EC; Viarheichyk H; Morales H; Costes V; Félix A; Germar MJ; Mena M; Ruacan A; Jain A; Mehrotra R; Goodman MT; Lombardi LE; Ferrera A; Malami S; Albanesi EI; Dabed P; Molina C; López-Revilla R; Mandys V; González ME; Velasco J; Bravo IG; Quint W; Pawlita M; Muñoz N; de Sanjosé S; Xavier Bosch F; J Natl Cancer Inst; 2016 Jun; 108(6):djv403. PubMed ID: 26823521 [TBL] [Abstract][Full Text] [Related]
5. Comparison of Molecular Assays for HPV Testing in Oropharyngeal Squamous Cell Carcinomas: A Population-Based Study in Northern Ireland. Craig SG; Anderson LA; Moran M; Graham L; Currie K; Rooney K; Robinson M; Bingham V; Cuschieri KS; McQuaid S; Schache AG; Jones TM; McCance D; Salto-Tellez M; McDade SS; James JA Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):31-38. PubMed ID: 31666283 [TBL] [Abstract][Full Text] [Related]
6. Accuracy of high-risk HPV DNA PCR, p16 Simoens C; Gheit T; Ridder R; Gorbaslieva I; Holzinger D; Lucas E; Rehm S; Vermeulen P; Lammens M; Vanderveken OM; Kumar RV; Gangane N; Caniglia A; Maffini F; Rubio MBL; Anantharaman D; Chiocca S; Brennan P; Pillai MR; Sankaranarayanan R; Bogers J; Pawlita M; Tommasino M; Arbyn M; BMC Infect Dis; 2022 Aug; 22(1):676. PubMed ID: 35933382 [TBL] [Abstract][Full Text] [Related]
7. Double Positivity for HPV DNA/P16 Alsharif U; Hofmann M; Gebhard M; Tharun L; Rades D; Sieg P; Hakim SG Anticancer Res; 2021 Nov; 41(11):5557-5568. PubMed ID: 34732426 [TBL] [Abstract][Full Text] [Related]
8. Human Papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK population. Evans M; Newcombe R; Fiander A; Powell J; Rolles M; Thavaraj S; Robinson M; Powell N BMC Cancer; 2013 May; 13():220. PubMed ID: 23634887 [TBL] [Abstract][Full Text] [Related]
10. The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer. Sznurkowski JJ; Żawrocki A; Biernat W BMC Cancer; 2016 Jul; 16():465. PubMed ID: 27411473 [TBL] [Abstract][Full Text] [Related]
11. HPV-related Oropharyngeal Squamous Cell Carcinoma: p16INK4A Immunohistochemistry or HPV Genotyping? Orsaria M; Marzinotto S; De Marchi L; Giacomarra V; Boria S; Rubini C; Londero AP; Di Loreto C; Mariuzzi L Anticancer Res; 2015 Sep; 35(9):4733-9. PubMed ID: 26254363 [TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis. Mehanna H; Taberna M; von Buchwald C; Tous S; Brooks J; Mena M; Morey F; Grønhøj C; Rasmussen JH; Garset-Zamani M; Bruni L; Batis N; Brakenhoff RH; Leemans CR; Baatenburg de Jong RJ; Klussmann JP; Wuerdemann N; Wagner S; Dalianis T; Marklund L; Mirghani H; Schache A; James JA; Huang SH; O'Sullivan B; Nankivell P; Broglie MA; Hoffmann M; Quabius ES; Alemany L; Lancet Oncol; 2023 Mar; 24(3):239-251. PubMed ID: 36796393 [TBL] [Abstract][Full Text] [Related]
13. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab. Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222 [TBL] [Abstract][Full Text] [Related]
14. P16INK4A as a surrogate biomarker for human papillomavirus-associated oropharyngeal carcinoma: consideration of some aspects. Wang H; Sun R; Lin H; Hu WH Cancer Sci; 2013 Dec; 104(12):1553-9. PubMed ID: 24344719 [TBL] [Abstract][Full Text] [Related]
15. HPV-relatedness definitions for classifying HPV-related oropharyngeal cancer patient do impact on TNM classification and patients' survival. Taberna M; Mena M; Tous S; Pavón MA; Oliva M; León X; Garcia J; Guix M; Hijano R; Bonfill T; Aguilà A; Alemany L; Mesía R PLoS One; 2018; 13(4):e0194107. PubMed ID: 29664911 [TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus as a favorable prognostic biomarker in squamous cell carcinomas of the vagina. Alonso I; Felix A; Torné A; Fusté V; del Pino M; Castillo P; Balasch J; Pahisa J; Rios J; Ordi J Gynecol Oncol; 2012 Apr; 125(1):194-9. PubMed ID: 22226684 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of HPV DNA and p16 Urbute A; Rasmussen CL; Belmonte F; Obermueller T; Prigge ES; Arbyn M; Verdoodt F; Kjaer SK Cancer Epidemiol Biomarkers Prev; 2020 Apr; 29(4):703-710. PubMed ID: 32051192 [TBL] [Abstract][Full Text] [Related]
18. High-risk HPV DNA status and p16 (INK4a) expression as prognostic markers in patients with squamous cell cancer of oral cavity and oropharynx. Śnietura M; Jaworska M; Pigłowski W; Goraj-Zając A; Woźniak G; Lange D Pol J Pathol; 2010; 61(3):133-9. PubMed ID: 21225495 [TBL] [Abstract][Full Text] [Related]
19. HPV DNA genotyping, HPV E6*I mRNA detection, and p16 Simoens C; Gorbaslieva I; Gheit T; Holzinger D; Lucas E; Ridder R; Rehm S; Vermeulen P; Lammens M; Vanderveken OM; Kumar RV; Gangane N; Caniglia A; Maffini F; Rubio MBL; Anantharaman D; Chiocca S; Brennan P; Pillai MR; Sankaranarayanan R; Bogers J; Pawlita M; Tommasino M; Arbyn M; Cancer Epidemiol; 2021 Jun; 72():101925. PubMed ID: 33839457 [TBL] [Abstract][Full Text] [Related]
20. Role of Human Papillomavirus Infection in Head and Neck Cancer in Italy: The HPV-AHEAD Study. Tagliabue M; Mena M; Maffini F; Gheit T; Quirós Blasco B; Holzinger D; Tous S; Scelsi D; Riva D; Grosso E; Chu F; Lucas E; Ridder R; Rrehm S; Bogers JP; Lepanto D; Lloveras Rubio B; Vijay Kumar R; Gangane N; Clavero O; Pawlita M; Anantharaman D; Radhakrishna Pillai M; Brennan P; Sankaranarayanan R; Arbyn M; Lombardi F; Taberna M; Gandini S; Chiesa F; Ansarin M; Alemany L; Tommasino M; Chiocca S; The Hpv-Ahead Study Group Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33260360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]